Discussion

This talk will provide an update on the preclinical and clinical data of therapeutic drugs that include the AlbudAbTM half-life extension technology. It will cover lead discovery process/engineering and the selection of formats for improved biological, biophysical and pharmacokinetic properties, focussing on key in vivo and clinical data.